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ABSTRACT: Metabolic proﬁling by 1H NMR spectroscopy is an
underutilized technology in salivary research, although preliminary
studies have identiﬁed promising results in multiple ﬁelds (diagnostics,
nutrition, sports physiology). Translation of preliminary ﬁndings into
validated, clinically approved knowledge is hindered by variability in
protocol for the collection, storage, preparation, and analysis of saliva.
This study aims to evaluate the eﬀects of diﬀering sample
pretreatments on the 1H NMR metabolic proﬁle of saliva. Protocol
considerations are highly varied in the current literature base, including
centrifugation, freeze−thaw cycles, and diﬀerent NMR quantiﬁcation
methods. Our ﬁndings suggest that the 1H NMR metabolite proﬁle of
saliva is resilient to any change resulting from freezing, including
freezing of saliva prior to centrifuging. However, centrifugation was
necessary to remove an unidentiﬁed broad peak between 1.24 and 1.3
ppm, the intensity of which correlated strongly with saliva cellular content. This peak obscured the methyl peak from lactate and
signiﬁcantly aﬀected quantiﬁcation. Metabolite quantiﬁcation was similar for saliva centrifuged between 750g to 15 000g.
Quantiﬁcation of salivary metabolites was similar whether quantiﬁed using internal phosphate-buﬀered sodium trimethylsilyl-
[2,2,3,3-2H4]-propionate (TSP) or external TSP in a coaxial NMR tube placed inside the NMR tube containing the saliva sample.
Our results suggest that the existing literature on salivary 1H NMR will not have been adversely aﬀected by variations of the
common protocol; however, use of TSP as an internal standard without a buﬀered medium appears to aﬀect metabolite
quantiﬁcation, notably for acetate and methanol. We include protocol recommendations to facilitate future NMR-based studies
of saliva.
KEYWORDS: saliva, NMR, metabolomic proﬁling, protocol standardization
■ INTRODUCTION
Saliva is a useful ﬂuid for biomedical analysis due to its
inherently simple, noninvasive collection and its diverse
composition, constituting both host and microbial DNA,
RNA, proteins, peptides, and metabolites.1,2 In the past decade,
considerable advances have been made using saliva as a source
of diagnostic and prognostic biomarkers;3−5 however, the
translation of preliminary research ﬁndings into validated
clinical recommendations is still largely unrealized at present.6
This is particularly true regarding use of salivary metabolites as
biomarkers, where considerable work is necessary to stand-
ardize protocols across analytical platforms.7 Although the
majority of metabolic analyses of saliva are performed using
mass-spectroscopy (MS)-based platforms, preliminary 1H-
NMR-based studies have been demonstrated to reveal
metabolic changes for multiple diseases. These include oral
conditions such as dental caries,8 periodontal disease,9 and
Sjögren’s syndrome10 as well as systemic conditions such as
dementia.11 Other studies of salivary metabolite composition
have investigated eﬀects of factors such as smoking,12
exercise,13 dietary standardization,14,15 gender, body mass
index16 and diurnal eﬀects.17 The inﬂuence of salivary
metabolite composition has been studied in the context of
gustation18 and nutrition.19 Forensic applications of salivary 1H
NMR metabolite proﬁling have also been investigated.20,21
Metabolic proﬁling of saliva by 1H NMR spectroscopy is
underutilized compared with proﬁling of plasma and urine. This
disparity is illustrated in Figure 1A, in which the number of
publications returned by the Web of Science search engine for
the terms “urine/plasma/saliva NMR metabolomics” by year
and the proportion of NMR-based metabolomic studies as
percentage of total publications in the ﬁeld are shown. Figure
1B reveals that the proportion of NMR proﬁling studies of
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plasma and saliva is comparable; however, methodology in the
former is considerably more established.
1H-NMR-based metabolic research of urine and plasma is
facilitated by the availability of validated and published
guidelines encompassing the collection, storage, preparation,
and analysis of these bioﬂuids.22,23 These guidelines achieve
two signiﬁcant goals: First, new researchers to the ﬁeld can
conﬁdently undertake research by following these speciﬁca-
tions, and, second, comparison of results between diﬀerent
studies can be readily made. Consequently, research ﬁndings
for 1H NMR metabolite proﬁling of plasma and urine are
rapidly approaching translation into clinical recommenda-
tions.24,25
No two studies of saliva by 1H NMR spectroscopy follow the
same protocol. A selection of protocols is presented in Table 1,
highlighting the degree of variability that exists in the current
literature.
Protocol variability concerns several key aspects of sample
preparation including centrifugation force and whether
centrifugation was performed before or after initial freezing.
The need to centrifuge saliva to remove cellular content
(including host epithelial cells, leucocytes, and bacterial cells)
before analysis is widely reported.28 Centrifugation has been
shown to signiﬁcantly aﬀect the rheological and lubricant
properties of saliva;29,30 however, there are no formal studies of
centrifugation eﬀects on the 1H NMR metabolic proﬁle of
saliva.
Freezing of saliva has been shown to alter the protein
composition measured by MS and gel electrophoresis due to
precipitation of salivary proteins.28,31 No literature exists on the
eﬀects of freeze−thaw events on salivary metabolite concen-
tration measured by 1H NMR. A second unknown consid-
eration regarding freeze−thaw processes is whether any
diﬀerence occurs due to freezing whole-mouth saliva (WMS)
before centrifugation (i.e., with cellular component present) or
freezing supernatant following centrifugation. As shown in
Table 1, both methods have been adopted.
Another protocol consideration with potential to greatly
impact the data obtained from 1H NMR spectra of saliva is the
method of quantiﬁcation. To quantify metabolites in absolute
terms, the use of an NMR standard of known concentration is
required. The majority of studies on saliva use TSP (sodium
trimethylsilyl-[2,2,3,3-2H4]-propionate) as a standard, directly
mixed with the sample ﬂuid. Such a practice is already known to
be inappropriate for plasma as TSP binds to protein and the
resulting signal is broadened/reduced, leading to higher
metabolite concentrations.22 It has been observed that the
relatively low protein concentration in saliva compared with
plasma may avoid this problem; however, this has not been
assessed statistically.17 Furthermore, the addition of buﬀered or
nonbuﬀered standards is a variable that has not been evaluated.
The present study was therefore designed to evaluate the
eﬀects of centrifugation, freeze−thaw, and quantiﬁcation
methods on quantiﬁcation of typical saliva metabolites: how
Figure 1. (A) Cumulative publications returned when searching “urine/plasma/saliva NMR metabolomics” in Web of Science by year. (B) Number
of NMR-based metabolomic studies as a percentage of total research concerning the relevant bioﬂuid (studies featuring “human urine/plasma/saliva”
in the title).
Table 1. Summary of Protocol Variability in Existing 1H-NMR Spectroscopy Studies of Salivaa
protocol consideration
authors sample storage centrifugation quantiﬁcation method
Mikkonen et al., 201310 transferred to lab on ice, centrifuged (a), stored −20 °C,
defrosted, centrifuged (b)
(a) 3000g for 20 min at
4 °C
internal phosphate-buﬀered TSP
(b) 10 000g for 5 min at
4 °C
Silwood et al., 200217 transferred to lab on ice, centrifuged, stored −70 °C unspeciﬁed internal unbuﬀered TSP; external
TSP in coaxial NMR tube
Wallner-Liebmann et al., 201615 samples frozen at −20 °C, transferred to liquid nitrogen within
60 h; thawed at room temperature, centrifuged
14 000 rpm for 30 min at
4 °C
internal phosphate-buﬀered TSP
Takeda et al., 200912 samples frozen at −80 °C, thawed, centrifuged 3000 rpm internal unbuﬀered DSS
Dame et al., 201526 samples centrifuged, stored at −20 °C then ultraﬁltered (3 kDa
ﬁlter)
10 000 rpm for 10 min internal DSS in deproteinated
samples
Neyraud et al., 201327 samples centrifuged (a), stored at −80 °C, thawed and
centrifuged (b)
(a) 15 000g for 30 min internal TSP
(b) 5000g for 10 min
Bertram et al., 200916 transferred to lab at 4 °C, centrifuged, stored at −20 °C 2000g for 10 min internal TSP
aTSP, sodium trimethylsilyl-[2,2,3,3-2H4]-propionate; DSS, 4,4-dimethyl-4-silapentane-1-sulfonic acid.
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diﬀerent centrifugation forces and durations, freeze−thaw
eﬀects (including freezing of supernatant, freezing of WMS,
and four freeze−thaw cycles), quantiﬁcation method, external
standard in a coaxial NMR tube, internal buﬀered TSP, and
internal nonbuﬀered TSP aﬀect quantiﬁcation. The quantiﬁed
metabolites are listed in Table 2. By addressing these common
protocol variables found in the current literature base of salivary
1H NMR analysis, an evidence-based standardized protocol for
collection, storage, preparation, and analysis of saliva samples
by 1H NMR will be proposed. Additionally, this study will
determine the extent to which data from published literature
can be reasonably compared where protocol variability is
present.
■ EXPERIMENTAL SECTION
Saliva Collection
All research was conducted following approval from King’s
College London ethics committee (HR-15/15-2508). Unsti-
mulated WMS was collected into sterilized universal tubes.
Table 2. Summary of Metabolite Assignments and Concentration Ranges in 700 MHz CPMG 1H-NMR Spectra of Salivaa
metabolite (HMDB number)
chemical shift (ppm) and multiplicity of
characteristic resonancesb assignment
mean ± SEM salivary
concentration (μM)
range of salivary metabolite
concentrations (μM)
acetate (0000042) 1.92, singlet CH3 3670.0 ± 236.0 2672.0−4780.0
acetoin (0003243) 1.37, doublet CH3 43.1 ± 3.8 25.2−64.5
2.21, singlet CH3
4.42, quartet CH
alanine (0000161) 1.47, doublet CH3 97.1 ± 13.5 49.2−207.4
3.76, quartet CH
butyrate (0000039) 0.88, triplet CH3 144.6 ± 11.8 87.0−196.9
1.55, multiplet CH2
2.14, triplet CH2
choline and choline-containing
compounds (0000097)
3.18, singlet CH3 21.1 ± 2.4 6.2−32.2
3.51, multipletc CH2
4.07, multipletc CH2
citrate (0000094) 2.51, doubletd CH2 49.0 ± 6.4 24.9−103.9
2.67, doubletd CH2
dimethylamine (0000087) 2.70, singlet CH3 11.5 ± 1.7 4.6−23.9
ethanol (0000108) 1.17, triplet CH3 98.2 ± 19.2 24.5−285
3.65, quartet CH2
formate (0000142) 8.45, singlet CH 102.6 ± 40.7 0.0−486.6
glycine (0000123) 3.54, singlet CH2 172.6 ± 18.0 58.2−255.1
histidine (0000177) 3.16, multiplet CH2 27.4 ± 5.3 5.6−61
3.23, multiplet CH2
3.98, multiplet CH
7.09, singlet CH
7.80, singlet CH
lactate (0000190) 1.33, doublet CH3 224.9 ± 55.2 50.1−647
4.1, quartet CH2
methanol (0001875) 3.34, singlet CH3 32.9 ± 3.3 16.0−48.3
methylamine (0000164) 2.60, singlet CH3 11.9 ± 0.8 6.9−15.9
phenylalanine (0000159) 3.19, multiplet CH2 42 ± 5.7 20.1−80.4
3.98, multiplet CH
7.32, doublet H2, 2′
7.36, multiplet H3, 3′
7.42, multiplet H4
propionate (0000237) 1.05, triplet CH3 517.4 ± 79.0 156.9−1039
2.17, quartet CH2
pyruvate (0000243) 2.36, singlet CH3 160.0 ± 19.3 56.8−262.3
succinate (0000254) 2.40, singlet CH2 81.6 ± 16.4 26.7−205.5
taurine (0000251) 3.25, triplet CH2 183.6 ± 29.2 90.8−396.2
3.42, triplet CH2
tyrosine (0000158) 3.02, multiplet CH2 42.0 ± 6.2 11.1−81.4
3.17, multiplet CH2
3.92, multiplet CH
6.88, multiplet H2, 2′
7.17, multiplet H3, 3′
trimethylamine 2.89, singlet CH3 3.3 ± 0.5 1.3−7.2
aMetabolites are quantiﬁed in unstimulated saliva (after centrifugation at 15 000g and a single freeze-thaw cycle) with quantiﬁcation using external
TSP in a coaxial tube (n = 12). The Table does not include metabolites that can be qualitatively detected but are not reliably quantiﬁed due to
superposition of other resonance frequencies. bResonances in italics are obscured in 1D 1H NMR spectra of saliva. cThese refer to chemical shifts for
choline only. dpH-sensitive chemical shifts.
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Saliva samples initially collected from participants who had
eaten within 1 h of sample collection and before, during, and 2
h post exercise (10 min of running upstairs) were observed to
modulate the 1H NMR spectra of saliva (see Supplementary
Figures S-1−S-3 and Table S-1). Thus for this study
participants were instructed to have refrained from eating,
drinking, and any oral activity (chewing gum, smoking,
undertaking oral hygiene procedures) in the hour preceding
collection time. Saliva was collected from a total of 12 healthy
volunteers (5 males, 7 females), ages 23−44, but sample
numbers varied for diﬀerent aspects of the study (detailed
below). Despite an interval of 1 h before sampling, resonances
from xylitol (present in some chewing gum) were still apparent
in the spectrum, although they were not observed to adversely
aﬀect metabolite quantiﬁcation (Supplementary Figure S-1).
Timing of collection was standardized as far as possible to
between 11:00 and 12:00 a.m. All saliva was kept on ice from
the moment of expectoration.
Reagents
Trypan blue, sodium trimethylsilyl-[2,2,3,3-2H4]-propionate
(TSP), deuterium oxide (D2O), 5 mm and 3 mm outer
diameter (OD) Bruker SampleJet NMR tubes, and glacial acetic
acid were purchased from Sigma-Aldrich (Poole, Dorset, UK).
Preliminary Determination of Appropriate Centrifugation
Forces
Saliva (5 mL) was collected from 11 individuals and gently
mixed to ensure homogeneity. Aliquots of 20 and 2 μL were
taken for counting eukaryotic and prokaryotic cells, respectively
(see below). Samples were then divided into 1 mL aliquots and
centrifuged at 330g, 750g, 1500g, 3000g, and 15 000g for 10 min
at 4 °C. Following centrifugation, eukaryotic and prokaryotic
cells were counted in the individual supernatants.
Cell Concentration
Saliva (20 μL) was mixed with 0.4% Trypan blue (20 μL) and
placed in a hemocytometer counting chamber and viewed
under a light microscope (500× magniﬁcation). Eukaryotic
cells were counted and classiﬁed as either oral epithelial cells
(∼50−70 μm diameter with a round prominent nucleus) or
leucocytes (∼10−30 μm diameter with pleomorphic nuclei).
Bacterial cells were counted by heat-ﬁxing 2 μL of the sample
to a glass slide, Gram staining, and viewing at 1250×
magniﬁcation. The ratio of the area of one ﬁeld of view to
the whole sample area was calculated, and stained bacterial cells
were counted.
Sample Preparation for 1H NMR Spectroscopy
Centrifugation. Approximately 6 mL of saliva was collected
from eight volunteers. Samples were gently agitated to ensure
homogeneity and kept on ice in all stages of preparation. Five
aliquots were taken and either not centrifuged or centrifuged at
750g, 1500g, 3000g, or 15 000 g for 10 min at 4 °C. Samples
were stored at −80 °C prior to analysis.
Saliva (500 μL) was added to 5 mm OD NMR tubes, and a
sealed coaxial 3 mm OD NMR tube containing 300 μL of 1
mM TSP in 50:50 D2O/milli-Q water was placed inside the 5
mm tube. To calculate the relative volumes of solution in the 5
and 3 mm tubes read by the NMR receiver coil, a precalibration
step was performed with 4 mM acetate in the 5 mm OD tube.
For each sample, residual eukaryotic cell concentration was
counted as described above.
Freeze−Thaw Treatments. For investigation into freeze−
thaw eﬀects, 4 mL of unstimulated WMS was collected from six
participants on the day of analysis, so that WMS could be
analyzed without freezing. Four aliquots were prepared as
follows: (A) −WMS (1 mL) was centrifuged at 15 000 g for 10
min at 4 °C and kept on ice. (B) Same as for A but the
supernatant was frozen at −80 °C and thawed on ice prior to
analysis. (C) 1 mL of WMS was frozen at −80 °C and thawed
on ice, then centrifuged at 15 000g for 10 min at 4 °C and kept
on ice prior to analysis, performed within 3 h of collection. (D)
Same as for B but the aliquot underwent four freeze−thaw
cycles prior to analysis. Samples were frozen at −80 °C and
thawed on ice in a cold room at 4 °C. The freezing step was for
0.5 h, and the thawing took ∼45 min. Samples were prepared
with TSP in the 3 mm OD NMR tubes (for external
quantiﬁcation method), as described below.
Quantiﬁcation Method. Residual saliva from the 15 000g
aliquot was then subdivided for quantiﬁcation method
comparisons with both buﬀered and unbuﬀered internal TSP.
Unbuﬀered samples were prepared by adding 60 μL of 0.5 mM
TSP in D2O to 240 μL supernatant, and buﬀered samples were
prepared in the same way, except the TSP was in phosphate
buﬀer (0.2 M Na2HPO4, 44 mM NaH2PO4, in D2O, pH 7.4).
Mean ± SD sample pH after buﬀer addition was 7.44 ± 0.08.
1H NMR Spectroscopy
Acquisition. One-dimensional 1H NMR spectra were
acquired on a Bruker Avance III spectrometer (Bruker Biospin,
Karlsruhe, Germany) operating at a proton frequency 700.2
MHz. Samples were kept in a refrigerated chamber at 277 K
prior to analysis and analyzed at 298 K following a 5 min period
for temperature equilibration. Spectra were acquired with a
Carr−Purcell−Meiboom−Gill (CPMG) spin−echo pulse
sequence with water presaturation to ﬁlter out broad
macromolecule resonances, a total echo time of 64 ms,
relaxation delay of 4 s, acquisition time of 2.32 s, and 256
transients collected with 64k data points following four dummy
scans, with a spectral width of 20 ppm (−5 to 15 ppm). Spectra
were also acquired for each sample using a NOESY pulse
sequence (see Supporting Information, Figure S-4), but all
quantiﬁcation was performed on the CPMG data.
Spectral Processing. Spectra were analyzed in TopSpin
3.5 (Bruker BioSpin). A 0.3 Hz exponential line broadening
function was applied before Fourier transformation and
automatic phase correction. Baselines were inspected and
polynomial baseline correction applied. Metabolite assignments
were made using Chenomx NMR suite 8.2 (Chenomx Inc.),
human metabolite database (http://www.hmdb.ca) and liter-
ature values. Metabolite peaks were manually integrated and
quantiﬁed relative to the TSP peak in each spectrum. The
metabolites listed in Table 2 were measured. Metabolites were
quantiﬁed based on the ratio of the integral of a known
assignment relative to the integral of the standard TSP peak.
This ratio was then adjusted to account for the ratio of
metabolite and TSP protons giving rise to the signals and the
diﬀerence in the volume measured by the probe-head for the
TSP in the central (coaxial) 3 mm NMR tube and the sample
in the 5 mm NMR tube. The latter explains the need for the
precalibration step with two standards of known concen-
tration.32 The conﬁguration of the tubes and the calculation
used is illustrated in Figure S-5. Where the internal standard
was used, proton ratios of the metabolite peak to the TSP peak
were calculated and then multiplied by the dilution factor of the
sample caused by the addition of the standard TSP solution. As
the TSP is not in contact with any protein that may be present
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in the sample, quantiﬁcation by this method is unaﬀected by
macromolecular binding to TSP.
Statistical Analysis. Data were inspected for normality and
analyzed by repeated measures ANOVA with Greenhouse−
Geisser correction of sphericity and a Bonferroni posthoc
pairwise comparison test in SPSS. In some instances,
interindividual variation in metabolite levels resulted in
signiﬁcant diﬀerences being detected by ANOVA but posthoc
tests failed to determine where the diﬀerences lay. To account
for this external intervariability in metabolite concentrations, in
the experiment to determine the eﬀects of centrifugation,
metabolite concentrations were normalized to the levels
measured in the uncentrifuged samples.
■ RESULTS
Centrifugation Eﬀects on Cell Types in Saliva
WMS contains abundant epithelial, leucocyte, and bacterial
cells. Centrifugation signiﬁcantly decreased the concentration
of all cell types in saliva (Figure 2), but cell concentrations were
similar irrespective of centrifugation speed applied. Thus
centrifugation forces of 750g, 1500g, 3000g, and 15 000g were
selected for investigation into eﬀects on metabolite concen-
trations.
1H NMR Spectral Overview of Saliva
A representative 1D 1H NMR spectrum of saliva is shown in
Figure 3, and the assignments and concentrations of
metabolites are summarized in Table 2. Metabolites typically
observed in 1D 1H NMR spectra include organic acids (lactate,
pyruvate, succinate, citrate), short-chain fatty acids (formate,
acetate, propionate, butyrate), amino acids (tyrosine, histidine,
phenylalanine, glycine, taurine), alcohols (methanol, ethanol),
and amines (methylamine, dimethylamine, trimethylamine).
The majority of the aforementioned metabolites are consis-
tently reported in studies proﬁling salivary metabolites by 1H
NMR. Additionally, we provide conﬁrmation of the assignment
of acetoin and refutation of the assignment of propylene glycol,
both recently reported in saliva,33 via 2D 1H−1H COSY spectra
(Figures S-6−S-8).
Dietary and Physiological Modulation of 1H NMR Spectra
of Saliva
Alterations in salivary metabolite composition were induced by
both recent food consumption and exercise. These results are
presented in detail in the Supporting Information. Notably,
these included the presence of carbohydrate resonances
obscuring other metabolite resonances when collecting saliva
<1 h after eating (Figure S-1A), the eﬀects of intraoral
catabolism of dietary components (sucrose) on metabolites
such as lactate (Figure S-2), and exercise causing a generalized
increase in metabolite concentrations (Figures S-3A and S-3B).
Sample Preparation Eﬀects on 1H NMR Spectroscopy
Eﬀects of Centrifugation Force. All spectra of uncentri-
fuged saliva consistently featured a broad resonance between
∼1.24 and 3.0 ppm (labeled “U”, Figure 4), which overlapped
the lactate doublet at ∼1.32 ppm. In most cases, this peak was
suppressed by the lowest centrifugation force (750g) but
persisted in some cases, albeit diminishing with increasing
centrifugation force. Lactate quantiﬁcation was aﬀected by the
presence of U, with overestimation of the lactate concentration
in the uncentrifuged aliquot compared with those subjected to
centrifugation at 750g, 3000g, and 15 000g (p = 0.024, 0.012,
and 0.008, respectively). The only other metabolites whose
quantiﬁcation changed as a result of centrifugation were choline
and choline-containing compounds such as phosphatidycholine
(PtdCho), with diﬀerences being detected only between
Figure 2. Reduction in epithelial cells, leucocytes, and bacterial cells in saliva following centrifugation (repeated measures ANOVA and Bonferroni
posthoc test, n = 8). Bacterial cells are normalized to uncentrifuged levels due to large interindividual variation (between 2.91 × 107 and 8.93 × 108
cells/mL).
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noncentrifuged samples and centrifugation at 1500g (p < 0.05;
Figure 5A). ANOVA p values for acetoin and alanine were
<0.05; however, posthoc testing failed to report a diﬀerence
between the groups. In both cases, noncentrifuged samples had
generally higher concentrations than centrifuged samples.
Because of the proximity of these resonances to peak U, this
likely reﬂects the same eﬀects seen with lactate but to a lesser
extent. Data are presented in Table S-2.
Subsequent analysis of the saliva showed a highly signiﬁcant
linear correlation (p < 10−4) between the total eukaryotic cell
content and the integral of the region, 1.24 to 1.30 ppm, as a
surrogate measure of U (Figure 6A). Peak U may therefore
arise from lipidic aliphatic side chains of cell membrane
components. Lipid side chains of lipoproteins contribute to a
similar spectral peak in plasma spectra.34 Concentrations of
choline and choline-containing metabolites were found to
signiﬁcantly correlate only with epithelial cells present in
noncentrifuged samples (Figure 6B).
Eﬀects of Freezing. Spectral proﬁles of centrifuged fresh
saliva, saliva centrifuged prior to freeze−thawing, saliva
centrifuged post freeze−thawing and centrifuged saliva subject
to four freeze−thaw cycles were similar (Figure S-9). This was
true for all samples. No signiﬁcant diﬀerences were found
between the diﬀerent groups of sample treatments for any of
the metabolites listed in Table 2. Data are presented in Table S-
3.
Eﬀects of Quantiﬁcation Method. No signiﬁcant diﬀer-
ences in quantiﬁcation were detected when quantifying via
buﬀered internal TSP and external TSP in a coaxial tube. When
quantiﬁcation was performed using unbuﬀered TSP, signiﬁcant
diﬀerences were detected against external TSP for acetate and
methanol (p < 0.05), Figure 5B. Data are presented in Table S-
4.
Figure 3. Representative 700 MHz 1D-CPMG 1H NMR spectrum (64 ms echo time) of saliva between 0.70 and 8.50 ppm. The residual water signal
between 4.40 and 5.50 ppm has been removed. The vertical scale for the regions, 2.50−4.50 ppm and 5.00 to 8.50 ppm, has been doubled and
increased by a factor of four times, respectively. Saliva was centrifuged at 15 000g prior to freezing, with quantiﬁcation via external TSP in a coaxial
tube. The acetate peak has been truncated.
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■ DISCUSSION
The absence of methodological standardization has been
identiﬁed as a primary cause of inconsistent results in the
search for salivary proteomic and metabolomic biomarkers.35,36
This study proposes a standard protocol for 1D 1H NMR
spectroscopy of saliva. Given that this ﬁeld is relatively
underexplored compared with genomic or MS proteomic
proﬁling of saliva, early adoption of standardization is desirable.
Additionally, with the variability in sample preparation for
NMR analysis in the existing literature (see the Introduction),
investigation into the eﬀects of diﬀerent sample preparation
methods on salivary 1H NMR spectra can assist in comparing
studies.
Despite the ubiquity of centrifuging saliva samples, there are
relatively few studies examining the eﬀects of centrifugation on
subsequent 1H NMR analyses. For example, excessive
centrifugation force has been recognized to cause membrane
damage in many cell types, which could theoretically alter the
1H NMR metabolite proﬁle of biological ﬂuids.37,38 One study
has investigated the eﬀect of centrifugation on mass spectros-
copy proﬁles of saliva, comparing forces of 1000g and 10 000g.
The authors report that despite seeing diﬀerences in peak
intensity, centrifugation had a “minimal eﬀect”, although no
formal statistical analysis of quantiﬁcation was reported.39 The
range of reported centrifugation forces for saliva is between
2000g and 15 000g (see the Introduction). Our ﬁndings show
that quantifying acetate, lactate, or propionate in saliva
centrifuged at 750g, 1500g, 3000g and 15 000g was comparable.
Thus results from previous studies using such centrifugation
forces are comparable. However, diﬀerences in quantifying
lactate were observed if saliva samples were not spun due to the
presence of an unassigned peak that was proportional to the
cell content of samples. Thus centrifugation is necessary for the
removal of cells to prevent this peak overlapping the lactate
doublet at 1.32 ppm, leading to errors in quantiﬁcation of
lactate. This peak was seen to persist in one individual at forces
up to 1500g. Given that high centrifugal force did not aﬀect
metabolite concentrations, whereas too low a centrifugation
force may lead to residual cell contamination, centrifugation at
15 000g is advisable. Similarly, the higher content of choline
Figure 4. Partial 700 MHz CPMG 1H NMR spectra of samples from two participants (A,B). The unassigned broad peak (U) is removed by
centrifugation at 750g for participant A; however, for participant B this peak persists with centrifugation at 750g and 1500g. Centrifugation at 3000g
diminished peak U to the same extent as centrifuging at 15 000g. The superimposition of this peak on lactate is particularly noticeable in
uncentrifuged samples. Samples were centrifuged at 15 000g prior to freezing, with quantiﬁcation via external TSP in a coaxial tube.
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and choline-containing compounds in noncentrifuged samples
correlating with number of epithelial cells in the saliva may be
of cellular origin given PtdCho is a membrane phospholipid.40
The ability to provide absolute and reproducible quantiﬁca-
tion of metabolites in a complex ﬂuid environment with
minimal sample preparation is a key strength of 1H NMR
spectroscopy.41 Evaluation of NMR-based quantiﬁcation of
salivary metabolites is critical in validating the current literature
base and inﬂuencing future studies. Use of TSP as an internal
reference standard is the commonest approach to date. Such an
approach has been cautioned for protein-rich bioﬂuids such as
plasma due to protein binding of the standard;22 however, for
high-throughput spectroscopy, use of plasma buﬀer with
internal TSP has been described.23 Silwood et al., in one of
the earliest comprehensive 1H NMR analyses of saliva, describe
minimal eﬀects of protein binding due to the low protein
content of saliva, although no quantitative comparisons were
made. Our results ﬁnd that, provided internal TSP is buﬀered
with phosphate buﬀer (pH 7.4), quantiﬁcation was comparable
between internal TSP and external TSP in a coaxial NMR tube.
This is of particular importance as using coaxial NMR tubes is
less readily adaptable to a high-throughput approach or
automated sample preparation.
Timing of freezing and the eﬀects of repeated freeze−thaw
cycles is another methodological variable for salivary 1H NMR
spectroscopy that has not yet been assessed until this study.
Figure 5. (A) Eﬀects of centrifugation force resulting in signiﬁcant diﬀerences in quantiﬁcation of lactate and choline. Mean (±SEM) metabolite
concentrations are shown normalized to uncentrifuged levels (horizontal dashed line, 0g) to account for interindividual variation, (n = 8). (B)
Signiﬁcant diﬀerences in quantiﬁcation of acetate and methanol when measured by three diﬀerent methods (n = 8). Signiﬁcant diﬀerences detected
by a Bonferroni posthoc pairwise comparison following repeated measures ANOVA with Greenhouse−Geisser correction of sphericity are denoted
by * and ** (p < 0.05 and p < 0.01, respectively).
Figure 6. (A) Correlation between cell content and integral of region 1.24 and 1.30 ppm of the 700 MHz CPMG 1H NMR spectra of saliva
uncentrifuged and centrifuged at 750g, 1500g, 3000g, or 15 000g before a single freeze thaw cycle and quantiﬁed using external TSP (n = 39). (B)
Correlation between choline concentration and epithelial cell concentration in uncentrifuged saliva after a single freeze thaw cycle and quantiﬁed
using external TSP (n = 8).
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Freezing has been shown to alter the NMR spectra of plasma
by broadening lipoprotein peaks compared with fresh
samples.42 Furthermore, repeated freeze−thaw cycles have
also been shown to alter plasma NMR spectra, particularly after
the third cycle.43 Freezing of bioﬂuids prior to analysis is almost
always essential for logistical reasons. An important question to
address with regards to saliva is whether samples can be frozen
before centrifugation and removing the cell content. By
analogy, freezing of whole blood prior to conversion into
plasma or serum can result in hemolysis and leakage of
intracellular metabolites from cells in the blood.44,45 Regarding
saliva preparation, both approaches (freezing before and
freezing after centrifugation) have been adopted for 1H NMR
analysis (see the Introduction). Our results found no eﬀects of
freezing on either centrifuged or uncentrifuged saliva with
respect to quantiﬁcation of a number of metabolites compared
with fresh (nonfrozen) supernatant. Additionally, repeated
freeze−thaw cycles up to four times had no eﬀect on
quantifying metabolites. This knowledge is useful, for example,
in studies where participants collect their own samples
immediately upon waking;15 samples must be frozen before
transport for processing in a laboratory setting.
An important consideration that all existing literature
regarding saliva collection and preparation for 1H NMR
analysis has in common is the need to keep samples chilled.
Samples were kept at 4 °C or lower from the moment they
were expectorated including during centrifugation, while
thawing, and awaiting analysis in the NMR spectrometer. The
use of metabolic inhibitors including sodium ﬂuoride or sodium
azide is described in the salivary 1H NMR literature.15,17,46
However, there is evidence that the introduction of sodium
ﬂuoride can alter the 1H NMR metabolite proﬁle. MS analysis
of oral bioﬁlms has shown that sodium ﬂuoride, an enolase
inhibitor, results in an increase in 3-phosphoglycerate, albeit at
levels below the detection threshold of 1H NMR.47 Sodium
ﬂuoride has also been shown to alter the citrate peaks of 1H
NMR spectra of urine.48 Sodium azide, an inhibitor of
cytochrome oxidase, has been shown to have no eﬀect on the
degradation of plasma lipoprotein at room temperature as
lipolytic enzymes are not aﬀected by azide.41 A study validating
biobanking of urine and plasma for 1H NMR metabolomic
studies recommends careful temperature control (<4 °C) of
samples to inhibit cellular and enzymatic processes and
cautions the addition of enzyme inhibitors to samples.49
Validation of saliva biobanking has revealed that maintaining
saliva at 4 °C for 24 h before freezing causes minimal eﬀect
when compared with samples frozen immediately, although
nitrite levels were found to decrease.50
A ﬁnal protocol consideration for saliva collection prior to 1H
NMR analysis concerns timing of collection with respect to
both time of day and timing of other activities. Salivary ﬂow and
composition is under circadian control,51 and more recent
evidence suggests that a minority of salivary metabolites
displays circadian ﬂuctuations.52 Collection should be stand-
ardized between participants as far as possible. The ﬁnding that
the 1H NMR metabolite proﬁle of saliva collected immediately
on waking is signiﬁcantly diﬀerent from samples collected later
in the day must also be taken into account.15 A range of
exogenous substances have been reported in the 1H NMR
spectra of saliva including dietary derived substances (e.g.,
aspartame, acesulfame-K, and caﬀeine) and substances from
oral care products (e.g., chlorhexidine, xylitol, triclosan, and
thymol).17 Most authors acknowledge the eﬀects exogenous
substances can have on the salivary 1H NMR spectrum by
asking participants to abstain from ingesting substances prior to
collection. We collected saliva at least 1 h after eating or having
undergone other oral activities based on previous observations
of carbohydrate levels in saliva. While this time period is
somewhat arbitrary, 1 h proved to be suﬃcient for elimination
of carbohydrate peaks obscuring salivary metabolites.
■ CONCLUSIONS
Despite considerable variability in literature regarding prepara-
tion of saliva for 1H NMR metabolic proﬁling, our ﬁndings
indicate that results are not likely to have been signiﬁcantly
altered by centrifugation parameters or freeze−thaw consid-
erations. We demonstrate that previous study protocols
quantifying metabolites in saliva by NMR spectroscopy using
unbuﬀered internal TSP referencing are generally satisfactory
for many metabolites, with the exception of acetate and
methanol. We present an evidence-based protocol for
preparation of saliva for 1H NMR metabolic proﬁling.
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